1. Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message?
2. US Food and Drug Administration. FDA approves first targeted therapy for lung cancer mutation previously considered resistant to drug therapy [Internet]. Accessed May 28, 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-first-targeted-therapy-lung-cancer-mutation-previously-considered-resistant-drug
3. Sotorasib for Lung Cancers with KRAS p.G12C Mutation
4. https://friendsofcancerresearch.org/.
5. Optimizing dosing in oncology drug development. Friends of Cancer Research Annual Meeting 2021 [Internet]. Accessed 2021. https://friendsofcancerresearch.org/publications/